Venture-Backed Startups
101,671 companies with verified investor relationships.
0 investors
0 investors
0 investors
0 investors
Biomaterials startup developing next-generation regenerative implants; closed a seed round led by Cocoon Capital.
1 investor
0 investors
0 investors
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases. The company uses data-driven approaches and bioinformatics to identify and develop its pipeline of aging-focused therapeutics.
7 investors
BioAlert offers the LP15 automated monitoring system that continuously detects Legionella bacteria in cooling towers using qPCR technology, delivering same-day results without manual sampling. It serves industrial operators, real estate managers, and other facility teams to prevent Legionnaires' disease outbreaks and maintain regulatory compliance.
1 investor
BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections. The technology is intended to help physicians select the correct antibiotic and support efforts to combat antibiotic resistance.
1 investor
Bioarchitech develops multifunctional cancer immunotherapies derived from viral genetic code, including an intravenous engineered Vaccinia virus therapy (BA-V151) for metastatic cancer and a self-amplifying RNA intratumoural therapy (BA-R166) for early-stage cancers. Its candidates aim to both kill tumour cells and induce anti-tumour immunity, with initial focus on oesophageal and lung cancer.
1 investor
0 investors
0 investors
Biobase provides a data infrastructure layer that normalizes, unifies, and indexes clinical data from disparate systems (EHRs, LIMS, HL7, FHIR, VCF, genomics) into one queryable, research-ready network. It connects healthcare institutions and life sciences/biopharma companies, letting users request patient cohorts in plain language while data stays in institutional custody with HIPAA-aligned de-identification and audit trails.
1 investor
0 investors
BioBlends develops biopreservation products that use volatile organic compounds from beneficial bacteria, combined with bioinformatics and experimental validation, to control preservative-resistant microorganisms and fungal contamination in food. Its solutions extend shelf life across food matrices without chemical residues, serving industrial food producers such as baked goods manufacturers.
1 investor
BioBond is a materials technology company developing plant-based, low-VOC adhesives and protective coatings for industries including packaging, construction, automotive, textiles, furniture, marine, and aerospace. Its products, such as the BioCoat SUP250 polyurethane coating, are made in the USA without added microplastics and target healthcare, commercial, industrial, and food-safe environments.
1 investor
Biobot pioneers wastewater epidemiology, monitoring pathogens and substances in sewage to provide real-time public health surveillance at the community level. The company serves public health agencies, vaccine manufacturers, and hospital systems globally.
9 investors
0 investors
0 investors
BioBTX develops ICCP technology that converts end-of-life plastic waste and biomass into renewable aromatics (benzene, toluene, and xylenes) for use as drop-in chemical building blocks in the chemical industry. Based in the Netherlands, it is building PETRA, a commercial-scale plant in Delfzijl, and licenses its technology for circular aromatics production.
2 investors
1 investor
0 investors
0 investors